Fueled by a federal grant aimed at countering a bioterrorist attack, scientists at a Providence, R.I., pharmaceutical company are banking on the collection of blood samples from nearly two dozen Vineyarders to help them develop a new vaccine against tularemia, the rare disease with an unexplained presence on Martha's Vineyard.
